PROQR THERAPEUTICS EO-04 (0PQ) — Tangible Net Worth Ratio
PROQR THERAPEUTICS EO-04 (0PQ) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets (€0.00) from net assets (€49.37 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of PROQR THERAPEUTICS EO-04 to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PROQR THERAPEUTICS EO-04 Tangible Net Worth Ratio (2021–2025)
This chart shows how PROQR THERAPEUTICS EO-04's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of €49.37 Million with intangible assets of €0.00 EUR. For live market cap and overall valuation, see market cap of PROQR THERAPEUTICS EO-04.
Annual Tangible Net Worth Ratio for PROQR THERAPEUTICS EO-04 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for PROQR THERAPEUTICS EO-04 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore PROQR THERAPEUTICS EO-04 capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | €49.37 Million | €0.00 | €112.76 Million | ▲ +0.0 pp |
| 2024 | 100.0% | €88.56 Million | €0.00 | €167.96 Million | ▲ +0.0 pp |
| 2023 | 100.0% | €41.39 Million | €0.00 | €137.88 Million | ▲ +0.0 pp |
| 2022 | 100.0% | €66.68 Million | €0.00 | €171.32 Million | ▲ +0.0 pp |
| 2021 | 100.0% | €113.23 Million | €0.00 | €209.58 Million | — |